Updated Jul 16, 2026
Saxena Nishant C has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $101K.

Saxena Nishant C appears in SEC filings associated with Corbus Pharmaceuticals Holdings, Inc. as of 2026-05-22. The filings identify the individual by name but do not publicly disclose a clear executive title in the context provided. The name may also be rendered as Nishant C. Saxena or Nishant Saxena in other documents. Based on available SEC data, there is no widely published biographical information about this person beyond the SEC filing context.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-03 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | P — Open-market purchase | 9.0K | $7.58 | $68K |
| 2026-06-03 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | P — Open-market purchase | 4.5K | $7.33 | $33K |
| 2026-05-22 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | A — Grant or award | 58.3K | $0.00 |
Saxena Nishant C appears in SEC filings associated with Corbus Pharmaceuticals Holdings, Inc. as of 2026-05-22. The filings identify the individual by name but do not publicly disclose a clear executive title in the context provided. The name may also be rendered as Nishant C. Saxena or Nishant Saxena in other documents. Based on available SEC data, there is no widely published…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($101K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Saxena Nishant C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.